Found 7 matching trials
Combining TLR9 Agonist With bNAbs for Reservoir Reduction and Immunological Control of HIV
PHASE2This study is designed to evaluate the safety and efficacy of lefitolimod a...
Location
Dept. of Internal Medicine, University of Utah
Randomized Study of Maintenance Therapy With MGN1703 in Patients With SCLC
PHASE2Evaluation of efficacy and safety of MGN1703 administered twice weekly subc...
Location
Medizinische Universitaet Innsbruck
Ipilimumab (Immunotherapy) and MGN1703 (TLR Agonist) in Patients With Advanced Solid Malignancies
PHASE1The goal of this clinical research study is to find the highest tolerable d...
Location
University of Texas MD Anderson Cancer Center
Efficacy Study of a Maintenance Therapy With Immunomodulator MGN1703 in Patients With Advanced Colorectal Carcinoma
PHASE2This is a phase 2, randomized, double-blind, multi-center clinical study to...
Location
Klinik für Innere Medizin I, Abteilung für Klinische Onkologie, Medizinische Universität Wien
Toll-like Receptor 9 Agonist Treatment in Chronic HIV-1 Infection
PHASE1Combination antiretroviral treatment (cART) effectively suppresses virus re...
Location
Department for Infectious Diseases, Aarhus University Hospital
Evaluation of MGN1703 Maintenance Treatment in Patients With mCRC With Tumor Reduction During Induction Treatment
PHASE3The purpose of this this trial is to prove the efficacy and safety of MGN17...
Location
Landesklinikum Krems
A Phase I Study to Assess Cardiac and General Safety and Pharmacokinetics of 60 mg MGN1703
PHASE1MGN1703 is being developed for use in treating cancerous tumors effecting t...
Location
Spaulding Clinical